Retour

GENFIT (EPA:GNFT) GENFIT Pipeline Day Highlights Diverse Product Portfolio in Underserved Liver Diseases

Directive transparence : information réglementée

17/11/2022 22:10

24/01/2023 22:10

GENFIT Announces 2023 Financial Calendar

05/01/2023 22:10

GENFIT to Participate in Upcoming Investor Conferences

17/11/2022 22:10

GENFIT Pipeline Day Highlights Diverse Product Portfolio in Underserved...

10/11/2022 22:10

GENFIT Reports Third Quarter 2022 Financial Information

25/10/2022 22:10

GENFIT Announces Compelling Results for Next-Generation Non-Invasive...

29/09/2022 22:10

GENFIT Announces Signature of the Share Purchase Agreement and the...

13/09/2022 22:10

FDA Grants GENFIT’s GNS561 Orphan Drug Designation for the Treatment of...

08/07/2022 22:10

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et...

25/05/2022 22:10

GENFIT: May 25, 2022 Combined Shareholders Meeting results

11/05/2022 22:10

GENFIT Reports First Quarter 2022 Financial Information (Unaudited...

Voir tous les communiqués de GENFIT